Ponce Financial CHRO granted stock and options

Ponce Financial Group’s Chief Human Resources Officer, Melissa Antonia DeLeon, reported new equity awards in company stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ponce Financial Group’s Chief Human Resources Officer, Melissa Antonia DeLeon, reported new equity awards in company stock. On February 9, 2026, she received 5,000 shares of common stock at $0, described as restricted stock units that vest 20% per year starting February 9, 2027.

She was also granted a 5,000-share non-premium stock option at $16.87 and several 1,000-share premium stock options with exercise prices of $18.56, $18.89, $19.23, $19.57, and $19.91, each vesting 20% annually beginning February 9, 2027 and expiring in 2036. The filing also lists existing non-premium options granted earlier and 6,512 shares of common stock held indirectly through an ESOP.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 10 txns

Insider DeLeon Melissa Antonia

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Non-Premium Stock Options	5,000	$16.87	$84K
Grant/Award	Premium Stock Optons	1,000	$18.56	$19K
Grant/Award	Premium Stock Options	1,000	$18.89	$19K
Grant/Award	Premium Stock Options	1,000	$19.23	$19K
Grant/Award	Premium Stock Options	1,000	$19.57	$20K
Grant/Award	Premium Stock Options	1,000	$19.91	$20K
Grant/Award	Common Stock	5,000	$0.00	$0.00
holding	Non-Premium Stock Options	--	--	--
holding	Non-Premium Stock Options	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Non-Premium Stock Options — 14,883 contracts for 9,883 underlying shares (Direct); Premium Stock Optons — 1,000 contracts (Direct); Premium Stock Options — 4,000 contracts (Direct); Common Stock — 5,000 shares (Direct); Common Stock — 6,512 shares (Indirect, By ESOP)

Footnotes (4)

F1. Shares of restricted stock units vest annually at a rate of 20% per year commencing on February 9, 2027.
F2. Stock options commence vesting annually at a rate of 20% starting on February 9, 2027
F3. Stock options commenced vesting annually at a rate of 20% starting on April 1, 2023.
F4. Stockkoptions commence vesting annually at a rate of 20% starting on February 4, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ponce Financial (PDLB) report for its CHRO?

Ponce Financial reported that Chief Human Resources Officer Melissa Antonia DeLeon received new equity awards. She was granted 5,000 shares of common stock at $0 and multiple stock option grants on February 9, 2026, as disclosed in a Form 4 insider filing.

How many Ponce Financial (PDLB) shares did the CHRO receive on February 9, 2026?

On February 9, 2026, the CHRO received 5,000 shares of Ponce Financial common stock at $0. These are restricted stock units that vest 20% each year starting February 9, 2027, according to the vesting schedule described in the filing’s footnotes.

What new stock options were granted to the Ponce Financial (PDLB) CHRO?

The CHRO received a 5,000-share non-premium stock option at $16.87 and several 1,000-share premium stock options with exercise prices from $18.56 to $19.91. All these options begin vesting 20% annually starting February 9, 2027 and expire in 2036.

What are the vesting terms of the Ponce Financial (PDLB) CHRO’s restricted stock units?

The filing states that the CHRO’s restricted stock units vest annually at a rate of 20% per year, beginning on February 9, 2027. This means the 5,000-share award will vest in equal installments over five years, subject to the plan’s conditions.

Does the Ponce Financial (PDLB) CHRO hold any indirect shares through an ESOP?

Yes. The Form 4 shows that the CHRO has indirect beneficial ownership of 6,512 shares of Ponce Financial common stock through an ESOP. These ESOP shares are reported separately from her directly held common stock and option positions in the filing.

What existing stock options for Ponce Financial (PDLB) does the CHRO report holding?

Beyond new grants, the CHRO reports holding 4,883 non-premium stock options at $10.44 expiring March 31, 2033, and 5,000 non-premium stock options at $13.31 expiring February 3, 2036. These earlier options also vest at 20% per year from their respective start dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/10/2026 - 03:55 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeLeon Melissa Antonia

(Last)

(First)

(Middle)

C/O PONCE BANK

2244 WESTCHESTER AVENUE

(Street)

BRONX

10462

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Ponce Financial Group, Inc. [ PDLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/09/2026		A		5,000	A	$0	5,000⁽¹⁾	D
Common Stock								6,512	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Premium Stock Options	$16.87	02/09/2026		A		5,000		02/09/2027	02/08/2036	Common Stock	5,000	$16.87	5,000⁽²⁾	D
Premium Stock Optons	$18.56	02/09/2026		A		1,000		02/09/2027	02/08/2036	Common Stock	1,000	$18.56	1,000	D
Premium Stock Options	$18.89	02/09/2026		A		1,000		02/09/2028	02/08/2036	Common Stock	1,000	$18.89	1,000	D
Premium Stock Options	$19.23	02/09/2026		A		1,000		02/09/2029	02/08/2036	Common Stock	1,000	$19.23	1,000	D
Premium Stock Options	$19.57	02/09/2026		A		1,000		02/09/2030	02/08/2036	Common Stock	1,000	$19.57	1,000	D
Premium Stock Options	$19.91	02/09/2026		A		1,000		02/09/2031	02/08/2036	Common Stock	1,000	$19.91	1,000	D
Non-Premium Stock Options	$10.44							04/01/2023	03/31/2033	Common Stock	4,883		4,883⁽³⁾	D
Non-Premium Stock Options	$13.31							02/04/2026	02/03/2036	Common Stock	5,000		5,000⁽⁴⁾	D

Explanation of Responses:

1. Shares of restricted stock units vest annually at a rate of 20% per year commencing on February 9, 2027.

2. Stock options commence vesting annually at a rate of 20% starting on February 9, 2027

3. Stock options commenced vesting annually at a rate of 20% starting on April 1, 2023.

4. Stockkoptions commence vesting annually at a rate of 20% starting on February 4, 2026.

	/s/ Megan Foscaldi, as attorney in fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR